Published in Nat Biotechnol on July 18, 2004
Recent perspectives in ocular drug delivery. Pharm Res (2008) 1.72
Applications of nanotechnology for immunology. Nat Rev Immunol (2013) 1.65
Nanovehicular intracellular delivery systems. J Pharm Sci (2008) 1.10
Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers. Polym Int (2007) 1.07
Nucleic acid-binding polymers as anti-inflammatory agents. Proc Natl Acad Sci U S A (2011) 0.98
Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation. Mol Pharm (2013) 0.94
[Inhibition of angiogenesis in the anterior chamber of the eye]. Ophthalmologe (2007) 0.94
Ocular drug delivery systems: An overview. World J Pharmacol (2015) 0.94
Partially glycosylated dendrimers block MD-2 and prevent TLR4-MD-2-LPS complex mediated cytokine responses. PLoS Comput Biol (2011) 0.93
Supramolecular assemblies of a conjugate of nucleobase, amino acids, and saccharide act as agonists for proliferation of embryonic stem cells and development of zygotes. Bioconjug Chem (2014) 0.90
Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth. Proc Natl Acad Sci U S A (2010) 0.90
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials. Br J Pharmacol (2014) 0.90
Accelerated healing of cutaneous leishmaniasis in non-healing BALB/c mice using water soluble amphotericin B-polymethacrylic acid. Biomaterials (2011) 0.87
Structural studies of biologically active glycosylated polyamidoamine (PAMAM) dendrimers. J Mol Model (2010) 0.87
Preventing acute gut wall damage in infectious diarrhoeas with glycosylated dendrimers. EMBO Mol Med (2012) 0.85
From sequence to 3D structure of hyperbranched molecules: application to surface modified PAMAM dendrimers. J Mol Model (2011) 0.84
Dendrimer-like PEO glycopolymers exhibit anti-inflammatory properties. J Am Chem Soc (2005) 0.83
Mannodendrimers prevent acute lung inflammation by inhibiting neutrophil recruitment. Proc Natl Acad Sci U S A (2013) 0.82
Innate immune activation by tissue injury and cell death in the setting of hematopoietic stem cell transplantation. Front Immunol (2015) 0.78
Study of self-made freeze-dried bilayered fibrin-binding amniotic membrane in ocular trabeculectomy in rabbits. Int J Ophthalmol (2011) 0.78
Collagen cross linking agents: design and development of a multifunctional cross linker. Photochem Photobiol (2008) 0.78
Wound Healing Versus Regeneration: Role of the Tissue Environment in Regenerative Medicine. MRS Bull (2010) 0.78
Controlling the cytokine storm in severe bacterial diarrhoea with an oral Toll-like receptor 4 antagonist. Immunology (2015) 0.77
Dendrimeric systems and their applications in ocular drug delivery. ScientificWorldJournal (2013) 0.77
Developing novel anti-fibrotic therapeutics to modulate post-surgical wound healing in glaucoma: big potential for small molecules. Expert Rev Ophthalmol (2015) 0.77
Solid-Phase Synthesis of 2-Aminoethyl Glucosamine Sulfoforms. J Carbohydr Chem (2012) 0.77
Nano-vectors for the Ocular Delivery of Nucleic Acid-based Therapeutics. Indian J Pharm Sci (2010) 0.76
The nucleic acid scavenger polyamidoamine third-generation dendrimer inhibits fibroblast activation and granulation tissue contraction. Plast Reconstr Surg (2014) 0.76
Glycomaterials for probing host-pathogen interactions and the immune response. Exp Biol Med (Maywood) (2016) 0.76
Computational design principles for bioactive dendrimer based constructs as antagonists of the TLR4-MD-2-LPS complex. Biomaterials (2011) 0.76
Clinical outcomes of amniotic membrane loaded with 5-FU PLGA nanoparticles in experimental trabeculectomy. Int J Ophthalmol (2015) 0.75
Sulfoform generation from an orthogonally protected disaccharide. Carbohydr Res (2012) 0.75
Glyconanomaterials for biosensing applications. Biosens Bioelectron (2015) 0.75
Nanoparticles and direct immunosuppression. Exp Biol Med (Maywood) (2016) 0.75
Pro-Inflammatory Versus Anti-Inflammatory Effects of Dendrimers: The Two Faces of Immuno-Modulatory Nanoparticles. Nanomaterials (Basel) (2017) 0.75
Glucosamine sulfate--environmental antibacterial activity. Clin Rheumatol (2009) 0.75
Alzheimer's disease. Lancet (2011) 5.35
A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature (2012) 4.08
Type IIA topoisomerase inhibition by a new class of antibacterial agents. Nature (2010) 3.58
Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol (2010) 2.72
Factors affecting the outcome of trabeculectomy: an analysis based on combined data from two phase III studies of an antibody to transforming growth factor beta2, CAT-152. Ophthalmology (2007) 2.19
Corneal Fine Needle Diathermy With Adjuvant Bevacizumab to Treat Corneal Neovascularization in Children. Cornea (2015) 1.94
Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur J Immunol (2002) 1.88
T-cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T-cell depletion. Cancer Res (2012) 1.74
Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers. J Immunol Methods (2008) 1.62
Polymer conjugates: nanosized medicines for treating cancer. Trends Biotechnol (2005) 1.53
Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J Immunol (2003) 1.52
Measuring strategic control in artificial grammar learning. Conscious Cogn (2011) 1.50
Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair. J Control Release (2008) 1.46
Intracellular fate of bioresponsive poly(amidoamine)s in vitro and in vivo. J Control Release (2009) 1.43
Drug repositioning for Alzheimer's disease. Nat Rev Drug Discov (2012) 1.42
Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci (2004) 1.41
A distinct chemokine axis does not account for enrichment of Foxp3(+) CD4(+) T cells in carcinogen-induced fibrosarcomas. Immunology (2015) 1.40
Intramuscular cobinamide sulfite in a rabbit model of sublethal cyanide toxicity. Ann Emerg Med (2010) 1.38
Monoclonal T-cell receptors: new reagents for cancer therapy. Mol Ther (2007) 1.34
Site-specific PEGylation of native disulfide bonds in therapeutic proteins. Nat Chem Biol (2006) 1.34
Suppression of tumour-specific CD4⁺ T cells by regulatory T cells is associated with progression of human colorectal cancer. Gut (2011) 1.33
PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity. Bioconjug Chem (2005) 1.27
Optimised anaesthesia to reduce post operative cognitive decline (POCD) in older patients undergoing elective surgery, a randomised controlled trial. PLoS One (2012) 1.21
Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors. Cancer Res (2010) 1.21
Disulfide bridge based PEGylation of proteins. Adv Drug Deliv Rev (2007) 1.19
A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy. Ophthalmology (2007) 1.18
Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking. Int J Neuropsychopharmacol (2011) 1.17
Association of drusen deposition with choroidal intercapillary pillars in the aging human eye. Invest Ophthalmol Vis Sci (2004) 1.17
Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge. Bioconjug Chem (2007) 1.16
Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males. Psychopharmacology (Berl) (2010) 1.16
Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells. J Control Release (2006) 1.15
Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer. Int J Oncol (2009) 1.15
Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines. Nanomedicine (Lond) (2013) 1.11
Recurrence of retinopathy of prematurity following bevacizumab monotherapy: is it only the tip of the iceberg? JAMA Ophthalmol (2013) 1.11
The heat-shock protein receptor CD91 is up-regulated in monocytes of HIV-1-infected "true" long-term nonprogressors. Blood (2003) 1.09
The generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen. J Immunol (2005) 1.09
S156C mutation in tissue inhibitor of metalloproteinases-3 induces increased angiogenesis. J Biol Chem (2009) 1.08
Polymer therapeutics: clinical applications and challenges for development. Adv Drug Deliv Rev (2009) 1.08
Polymer therapeutics designed for a combination therapy of hormone-dependent cancer. Angew Chem Int Ed Engl (2005) 1.06
Identification of a novel polymorphism in the 3'UTR of the L-arginine transporter gene SLC7A1: contribution to hypertension and endothelial dysfunction. Circulation (2007) 1.05
Cocaine- and amphetamine-regulated transcript (CART) signaling within the paraventricular thalamus modulates cocaine-seeking behaviour. PLoS One (2010) 1.05
Intraretinal and periretinal pathology in anterior proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol (2006) 1.01
Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice. Haematologica (2009) 1.00
Home sweet home: the tumor microenvironment as a haven for regulatory T cells. Front Immunol (2013) 0.99
Controversies in ocular trauma classification and management: review. Int Ophthalmol (2013) 0.99
Prediction of visual outcomes after open globe injury in children: a 17-year Canadian experience. J AAPOS (2013) 0.98
No change to HIV-1 latency with valproate therapy. AIDS (2006) 0.98
Bridging disulfides for stable and defined antibody drug conjugates. Bioconjug Chem (2014) 0.97
Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology. Eur J Immunol (2013) 0.96
Understanding endocytic pathways and intracellular trafficking: a prerequisite for effective design of advanced drug delivery systems. Adv Drug Deliv Rev (2003) 0.96
Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease. Dement Geriatr Cogn Disord (2008) 0.96
Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity. Eur J Immunol (2007) 0.96
Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer-Dox-AGM in breast cancer cells. J Control Release (2006) 0.94
Partially glycosylated dendrimers block MD-2 and prevent TLR4-MD-2-LPS complex mediated cytokine responses. PLoS Comput Biol (2011) 0.93
PEGylation of native disulfide bonds in proteins. Nat Protoc (2006) 0.93
Effect of PEG molecular weight and linking chemistry on the biological activity and thermal stability of PEGylated trypsin. Int J Pharm (2008) 0.93
Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptor. Blood (2003) 0.93
Emergency care in facial trauma--a maxillofacial and ophthalmic perspective. Injury (2005) 0.93
Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunity. Eur J Immunol (2012) 0.92
Polyacetal-doxorubicin conjugates designed for pH-dependent degradation. Bioconjug Chem (2003) 0.92
Chemokine receptor expression on mucosal dendritic cells from the endocervix of healthy women. J Infect Dis (2004) 0.91
Polymeric carriers: preclinical safety and the regulatory implications for design and development of polymer therapeutics. Adv Drug Deliv Rev (2009) 0.91
Effects of a multi-vitamin/mineral supplement on cognitive function and fatigue during extended multi-tasking. Hum Psychopharmacol (2010) 0.91
Hybrid polymer therapeutics incorporating bioresponsive, coiled coil peptide linkers. Biomacromolecules (2010) 0.90
Lens refilling to restore accommodation. J Cataract Refract Surg (2009) 0.90
Multiple proviral integration events after virological synapse-mediated HIV-1 spread. Virology (2013) 0.89
Optimisation of the degree of sulfation of a polymer based construct to block the entry of HIV-1 into cells. J Drug Target (2003) 0.89
Anomalous properties of spray dried solid dispersions. J Pharm Sci (2009) 0.89
Human MHC Class I-restricted high avidity CD4(+) T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo. Oncoimmunology (2013) 0.88
Fas ligand breaks tolerance to self-antigens and induces tumor immunity mediated by antibodies. Cancer Cell (2002) 0.88
Identification and insertion of 3-carbon bridges in protein disulfide bonds: a computational approach. Nat Protoc (2007) 0.88
Expression of the common heat-shock protein receptor CD91 is increased on monocytes of exposed yet HIV-1-seronegative subjects. J Leukoc Biol (2005) 0.87
Site-specific PEGylation at histidine tags. Bioconjug Chem (2012) 0.87
Enabling lead discovery for histone lysine demethylases by high-throughput RapidFire mass spectrometry. J Biomol Screen (2011) 0.87
Novel role of regulatory T cells in limiting early neutrophil responses in skin. Immunology (2010) 0.87
Accelerated healing of cutaneous leishmaniasis in non-healing BALB/c mice using water soluble amphotericin B-polymethacrylic acid. Biomaterials (2011) 0.87
Novel adaptations in motor cortical maps: the relation to persistent elbow pain. Med Sci Sports Exerc (2015) 0.87
Structural studies of biologically active glycosylated polyamidoamine (PAMAM) dendrimers. J Mol Model (2010) 0.87
Characterization and stability of ternary solid dispersions with PVP and PHPMA. Int J Pharm (2011) 0.87
Comparative binding of disulfide-bridged PEG-Fabs. Bioconjug Chem (2012) 0.86
HIV DNA two long terminal repeat circles: observations and interpretations. AIDS (2003) 0.86
Glass transitions in one-, two-, three-, and four-dimensional binary Lennard-Jones systems. J Phys Condens Matter (2008) 0.86
PEGylation and its impact on the design of new protein-based medicines. Future Med Chem (2014) 0.86
WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cells. Blood Cells Mol Dis (2007) 0.85
The effect of dextrin-rhEGF on the healing of full-thickness, excisional wounds in the (db/db) diabetic mouse. J Control Release (2011) 0.85